Spots Global Cancer Trial Database for Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Official Title: Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Study ID: NCT05834270
Study Description
Brief Summary: Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia
Detailed Description:
Keywords
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Faculty of Medicine, Shibīn Al Kawm, Menofia, Egypt
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
